Moderna | MRNA - Equity Capital And Reserves


Moderna reported $7.41B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 1.25B 20.68M Mar/2026
Agios Pharmaceuticals USD 1.11B 84M Mar/2026
Alnylam Pharmaceuticals USD 1.08B 286.2M Mar/2026
Amgen USD 9.19B 532M Mar/2026
Arrowhead Research USD 613.98M 45.56M Mar/2026
Biogen USD 18.65B 394.9M Mar/2026
BioMarin Pharmaceutical USD 6.21B 125.11M Mar/2026
Celltrion KRW 434.82B 1.14B Mar/2026
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Divis Laboratories Ltd INR 167.61B 13.48B Mar/2026
Gilead Sciences USD 23.52B 897M Mar/2026
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
Incyte USD 5.62B 455.37M Mar/2026
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Malin Corporation EUR 193.2M 75M Dec/2024
Moderna USD 7.41B 1.24B Mar/2026
Organigram Holdings CAD 371.81M 2.36M Mar/2026
Ovoca Bio EUR 1.26M 7.41M Jun/2025
Pharma Mar EUR 249.67M 2.16M Mar/2026
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Qiagen NV USD 3.78B 128.73M Dec/2025
Regeneron Pharmaceuticals USD 31.42B 166.7M Mar/2026
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Sarepta Therapeutics USD 1.51B 364.48M Mar/2026
Sartorius EUR 2.73B 1.14B Mar/2026
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Tilray USD 1.58B 39.08M Sep/2025
Ultragenyx Pharmaceutical USD -236M 156M Mar/2026
United Therapeutics USD 5.9B 1.2B Mar/2026
Vertex Pharmaceuticals USD 19.36B 696.1M Mar/2026
Zealand Pharma A/S 14.83B 331.99M Dec/2025
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026